Diagnosis of Pheochromocytoma with Hypertension
Plasma free metanephrines is the most sensitive and specific single test for diagnosing pheochromocytoma in patients with hypertension, with sensitivity of 96-100% and specificity of 89-98%. 1
Primary Diagnostic Tests
Biochemical Testing
First-line test: Plasma free metanephrines
Alternative or confirmatory tests:
Imaging Studies (after biochemical confirmation)
CT or MRI of abdomen and pelvis
Functional imaging (for confirming diagnosis or detecting multifocal disease):
Diagnostic Algorithm
Suspect pheochromocytoma in patients with:
- Paroxysmal or sustained hypertension
- Hypertension with headache, palpitations, or sweating
- Hypertension in patients >30 years with NF1
- Hypertension during pregnancy
- Orthostatic hypotension (in epinephrine-predominant tumors) 1
Biochemical confirmation:
Tumor localization:
- Perform MRI of abdomen and pelvis (preferred) or CT
- If negative but biochemical testing positive: proceed to functional imaging
- If multiple tumors suspected: use functional imaging 3
Important Clinical Considerations
- Fine needle biopsy of suspected pheochromocytoma is contraindicated due to risk of hypertensive crisis 3
- Biochemical testing should be performed before imaging studies 4
- In patients with known pheochromocytoma, long-term follow-up includes annual surveillance with plasma metanephrines 3
- False negatives can occur with plasma catecholamine measurements but are rare with urinary metanephrines 5
- Genetic testing should be considered in all patients with confirmed pheochromocytoma, especially those under 50 years 6
Pitfalls to Avoid
- Relying solely on plasma catecholamines, which can give falsely negative results 5
- Performing imaging before biochemical confirmation 4
- Using urinary vanillylmandelic acid (VMA) as the only test (lowest sensitivity at 64%) 2
- Performing fine needle biopsy on suspected adrenal pheochromocytoma 3
- Administering IV contrast for CT without proper alpha-blockade preparation 3
The diagnostic approach should follow this sequence: clinical suspicion → biochemical confirmation with plasma free metanephrines → anatomical and functional imaging for localization → genetic testing consideration. This approach ensures the highest diagnostic accuracy and patient safety.